Shuowu Liu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Single-cell analysis reveals a LAMB3-dependent immunosuppressive environment in gallbladder neck/cystic duct carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: May 16, 2025
The inwardly rectifying potassium channel KCNJ12 regulates the stemness of hepatocellular carcinoma cells through the Wnt/β-catenin pathway.
Journal: Journal of molecular cell biology
Published: May 01, 2025
PPP1R12B inhibits cell proliferation by inducing G0/G1 phase arrest via PAK2/β-catenin axis in hepatocellular carcinoma.
Journal: Frontiers in cell and developmental biology
Published: May 01, 2025
N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes.
Journal: iScience
Published: January 28, 2023
An RNA-RNA crosstalk network involving HMGB1 and RICTOR facilitates hepatocellular carcinoma tumorigenesis by promoting glutamine metabolism and impedes immunotherapy by PD-L1+ exosomes activity.
Journal: Signal transduction and targeted therapy
Published: May 30, 2021
MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt/β-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA.
Journal: Annals of translational medicine
Published: April 20, 2021
Treatment of murine lupus with TIGIT-Ig.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 01, 2019
EGFR/Notch Antagonists Enhance the Response to Inhibitors of the PI3K-Akt Pathway by Decreasing Tumor-Initiating Cell Frequency.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 21, 2018
CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity.
Journal: Nature communications
Published: March 26, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026